Status:
NOT_YET_RECRUITING
Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Family Centered
Black Ethnicity
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
To establish the efficacy of the family-centered intervention in improving healthy lifestyle behaviors (MVPA and overall diet quality), as well as physical functioning, QoL, and family health climate,...
Detailed Description
Primary Objectives • Determine the extent to which MVPA and overall diet quality have improved in Black PCa survivors and their caregivers in the family-centered intervention group, compared to those...
Eligibility Criteria
Inclusion
- Eligibility Criteria
- Survivors are eligible if they
- Are adults (≥18 years old)
- Self-identify as Black or African American;
- Were diagnosed with stage 0-III PCa; completed PCa treatment; (5) are able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q); and
- Have a family caregiver willing to participate together. Individuals under active surveillance for PCa will be included.
- Caregivers are eligible if they:
- Are adults (≥18 years old)
- Are able to be physically active, as determined by responses to the
- Exclusion Criteria
- Survivors are excluded if they:
- Have a prior history of other cancer or have metastatic cancer.
- Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period.
- Meet physical activity recommendations (i.e., 150 min of moderate intensity physical activity per week); and (4) are currently participating in a lifestyle or weight management program.
- Caregivers are excluded if they:
- Have serious medical conditions (e.g., cancer, congestive heart failure, stroke, and dementia)
- Are currently participating in a lifestyle or weight management program.
Exclusion
Key Trial Info
Start Date :
February 14 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2033
Estimated Enrollment :
648 Patients enrolled
Trial Details
Trial ID
NCT07164456
Start Date
February 14 2026
End Date
June 30 2033
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030